Monday, January 29, 2018 10:15 PM ET
Insiders Make Significant Sales of Galectin Therapeutics (GALT) Shares Reversing the recent Buying Trend
A substantial level of insider sales in Galectin Therapeutics was revealed in form 4 documents filed with the SEC today. Two insiders — James C Czirr, Director, and 10X Fund Lp, 10% Owner — disposed of 488,888 shares in the company having a market value of approximately $2,656,580. There have been 2 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been buys resulting in the purchase of 15,400 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 473,488 shares and have averaged 126,072 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Galectin Therapeutics is greater than its 191-company peer group average. The Biotechnology & Medical Research peer group saw 168 buy/sell trades during this period for an average of 0.9 transactions per company. However, the number of shares traded per transaction by Galectin Therapeutics insiders is lower than its peers. Within the peer group there were 14,746,492 shares purchased and 11,859,818 shares sold with company insiders having bought 25,102 shares on average over this time period.
The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* James C Czirr, Director, sold 244,444 shares
* 10X Fund Lp, 10% Owner, sold 244,444 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.